$1,000 invested Johnson & Johnson (2023)

A $1,000 investment in Johnson & Johnson at the start of 2023 grew to $1,565 by mid-2026, a return of +56.5%. The period began with the spinoff of its consumer health unit Kenvue, leaving the company focused on pharmaceuticals and medical devices, and the stock's maximum drawdown of 17.4% was notably mild. The S&P 500 gained +111.4% over the same stretch, ahead of the stock.